|
Xanax
Side Effects
|
Something Can Be Done About Xanax Side EffectsYou Can Make it! |
Xanax
side effects most common -
|
||||||
|
||||||||
Xanax side effects. Xanax side effects, Xanax side effect withdrawal solutions. Xanax side effects. There is a way to eliminate Xanax side effects without causing Xanax withdrawal side effects. Xanax side effects.
Xanax
Withdrawal
Xanax Side Effects
This site gives basic information about Xanax and other psychoactive medication.
Are you looking for Xanax answers?
The bestselling book, How to Get Off Psychiatric Drugs Safely, is available for FREE from The Road Back. Xanax withdrawal and Xanax side effect questions are answered from The Road Back site.
There are answers and there is a SOLUTION for Xanax effects. Click here to go to The Road Back for Xanax answers.
Xanax withdrawal - Body
Xanax withdrawal - Dry Mouth - The usual amount to moisture in the mouth is noticeably less.
Xanax withdrawal - Sweating Increased - A large quantity of perspiration that is medically caused.
Xanax withdrawal - Cardiovascular (Involving the heart and the blood vessels)
Xanax withdrawal - Palpitation - Unusual and not normal heartbeat, that is sometimes irregular, but rapid and forceful thumping or fluttering. It can be brought on by shock, excitement, exertion, or medical stimulants. A person is normally unaware of his/her heartbeat.
Xanax withdrawal - Hypertension - is high blood pressure, which is a symptom of disease in the blood vessels leading away from the heart. Hypertension is known as the “silent killer”. The symptoms are usually not obvious, however it can lead to damage to the heart, brain, kidneys and eye, and even to stroke and kidney failure. Treatment includes dietary and lifestyle changes.
Xanax withdrawal - Bradycardia - The heart rate is slowed from 72 beats per minute, which is normal, to below 60 beats per minute in an adult.
Xanax
withdrawal - Tachycardia
- The heart rate is speeded up to
above 100 beats per minute in an adult. Normal adult heart rate is 72 beats per
minute.
Xanax
withdrawal - ECG Abnormal
-
A test
called an electrocardiogram (ECG) that records the activity of the heart. It
measures heartbeats as will as the position and size of the heart’s four
chambers. It also measures if there is damage to the heart and the effects of
drugs or mechanical devices like a pacemaker on the heart. When the test is
abnormal this means that one or more of the following are present: heart
disease, defects, beating too fast or too slow, disease of the blood vessels
leading from the heart or of the heart valves, and/or a past or about to occur
heart attack.
Xanax withdrawal - Flushing - The skin all over the body turns red.
Xanax withdrawal - Varicose Vein - Unusually swollen veins near the surface of the skin that sometimes appear twisted and knotted, but always enlarged. They are called hemorrhoids when they appear around the rectum. The cause is attributed to hereditary weakness in the veins aggravated by obesity, pregnancy, pressure from standing, aging, etc. Severe cases may develop swelling in the legs, ankles and feet, eczema and/or ulcers in the affected areas.
Xanax withdrawal - Gastrointestinal (Involving the stomach and the intestines)
Xanax withdrawal - Abdominal Cramp/Pain - Sudden, severe, uncontrollable and painful shortening and thickening of the muscles in the belly. The belly includes the stomach as well as the intestines, liver, kidneys, pancreas, spleen, gall bladder, and urinary bladder.
Xanax withdrawal - Belching - Noisy release of gas from the stomach through the mouth; a burp.
Xanax withdrawal - Bloating - Swelling of the belly caused by excessive intestinal gas.
Xanax withdrawal - Constipation - Difficulty in having a bowel movement where the material in the bowels is hard due to a lack of exercise, fluid intake, and roughage in the diet, or due to certain drugs.
Xanax withdrawal - Diarrhea - Unusually frequent and excessive, runny bowel movements that may result in severe dehydration and shock.
Xanax withdrawal - Dyspepsia - Indigestion. This is the discomfort you experience after eating. It can be heartburn, gas, nausea, a bellyache or bloating.
Xanax withdrawal - Flatulence - More gas than normal in the digestive organs.
Xanax withdrawal - Gagging - Involuntary choking and/or involuntary throwing up.
Xanax withdrawal - Gastritis - A severe irritation of the mucus lining of the stomach either short in duration or lasting for a long period of time.
Xanax withdrawal - Gastroenteritis - A condition where the membranes of the stomach and intestines are irritated.
Xanax withdrawal - Gastroesophageal Reflux - A continuous state where stomach juices flow back into the throat causing acid indigestion and heartburn and possibly injury to the throat.
Xanax withdrawal - Heartburn - A burning pain in the area of the breastbone caused by stomach juices flowing back up into the throat.
Xanax withdrawal - Hemorrhoids - Small rounded purplish swollen veins that either bleed, itch or are painful and appear around the anus.
Xanax withdrawal - Increased Stool frequency - Diarrhea.
Xanax withdrawal - Indigestion - Unable to properly consume and absorb food in the digestive tract causing constipation, nausea, stomach ache, gas, swollen belly, pain and general discomfort or sickness.
Xanax withdrawal - Nausea - Stomach irritation with a queasy sensation similar to motion sickness and a feeling that one is going to vomit.
Xanax withdrawal - Polyposis Gastric - Tumors that grow on stems in the lining of the stomach, which usually become cancerous.
Xanax withdrawal - Swallowing Difficulty - A feeling that food is stuck in the throat or upper chest area and won’t go down, making it difficult to swallow.
Xanax withdrawal - Toothache - Pain in a tooth above and below the gum line.
Xanax withdrawal - Vomiting - Involuntarily throwing up the contents of the stomach and usually getting a nauseated, sick feeling just prior to doing so.
Xanax withdrawal - General
Xanax withdrawal - Allergy - The extreme sensitivity of body tissues triggered by substances in the air, drugs, or foods causing a reaction like sneezing, itching, asthma, hay fever, skin rashes, nausea and/or vomiting.
Xanax withdrawal - Anaphylaxis - A violent, sudden, and severe drop in blood pressure caused by a re-exposure to a foreign protein or a second dosage of a drug that may be fatal unless emergency treatment is given right away.
Xanax withdrawal - Asthenia - A physically weak condition.
Xanax withdrawal - Chest Pains - Severe discomfort in the chest caused by not enough oxygen going to the heart because of narrowing of the blood vessels or spasms.
Xanax withdrawal - Chills - Appearing pale while cold and shivering; sometimes with a fever.
Xanax withdrawal - Edema of Extremities - Abnormal swelling of the body’s tissue caused by the collection of fluid.
Xanax withdrawal - Fall - To suddenly lose your normal standing upright position as if you were shot.
Xanax withdrawal - Fatigue - Loss of normal strength so as to not be able to do the usual physical and mental activities.
Xanax withdrawal - Fever - Abnormally high body temperature, the normal being 98 degrees Fahrenheit or 37 degrees Centigrade in humans, which is a symptom of disease or disorder in the body. The body is affected by feeling hot, chilled, sweaty, weak and exhausted. If the fever goes too high, death can result.
Xanax withdrawal - Hot Flashes - Brief, abnormal enlargement of the blood vessels that causes a sudden heat sensation over the entire body. Women in menopause will sometimes experience this.
Xanax withdrawal - Influenza-like Symptoms - Demonstrating irritation of the respiratory tract (organs of breathing) such as a cold, sudden fever, aches and pains, as well as feeling weak and seeking bed rest, which is similar to having the flu.
Xanax withdrawal - Leg Pain - A hurtful sensation in the legs that is caused by excessive stimulation of the nerve endings in the legs and results in extreme discomfort.
Xanax withdrawal - Malaise - The somewhat unclear feeling of discomfort you get when you start to feel sick.
Xanax withdrawal - Pain in Limb - Sudden, sharp and uncontrolled leg discomfort.
Xanax withdrawal - Syncope - A short period of light headedness or unconsciousness (black-out) also know as fainting caused by lack of oxygen to the brain because of an interruption in blood flowing to the brain.
Xanax withdrawal - Tightness of Chest - Mild or sharp discomfort, tightness or pressure in the chest area (anywhere between the throat and belly). The causes can be mild or seriously life-threatening because they include the heart, lungs and surrounding muscles.
Xanax withdrawal - Hemic and Lymphatic Disorders (Involving the blood and the clear fluids in the tissues that contain white blood cells)
Xanax withdrawal - Bruise - Damage to the skin resulting in a purple-green-yellow skin coloration that’s caused by breaking the blood vessels in the area without breaking the surface of the skin.
Xanax withdrawal - Anemia - A condition where the blood is no longer carrying enough oxygen, so the person looks pale and easily gets dizzy, weak and tired. More severely, a person can end up with an abnormal heart, as well as breathing and digestive difficulties. The causes of anemia are not enough protein in the red blood cells, or missing and chemically destroyed red blood cells, as well as diseased or destroyed bone marrow.
Xanax withdrawal - Nosebleed - Blood lost from the part of the face that has the organs of smell and is where the body takes in oxygen.
Xanax withdrawal - Hematoma - Broken blood vessels that cause a swelling in an area on the body.
Xanax withdrawal - Lymphadenopathy Cervical - The lymph nodes in the neck, which are part of the body’s immune system get swollen and enlarge by reacting to the presence of a drug. The swelling is the result of the white blood cells multiplying in order to fight the invasion of the drug.
Xanax withdrawal - Metabolic and Nutritional Disorders (Energy and health)
Xanax withdrawal - Arthralgia - Sudden sharp nerve pain in one or more joints.
Xanax withdrawal - Arthropathy - Having joint disease or abnormal joints.
Xanax withdrawal - Arthritis - Painfully inflamed and swollen joints. The reddened and swollen condition is brought on by a serious injury or shock to the body either from physical or emotional causes.
Xanax withdrawal - Back Discomfort - Severe physical distress in the area from the neck to the pelvis along the backbone.
Xanax withdrawal - Bilirubin Increased - Bilirubin is a waste product of the breakdown of old blood cells. Bilirubin is sent to the liver to be made water-soluble so it can be eliminated from the body through emptying the bladder. A drug can interfere with or damage this normal liver function creating liver disease.
Xanax withdrawal - Decreased Weight - Uncontrolled and measured loss of heaviness or weight.
Xanax withdrawal - Gout - A severe arthritis condition that is caused by the dumping of a waste product called uric acid in the tissues and joints. It can become worse and cause the body to develop a deformity after going through stages of pain, inflammation, severe tenderness, and stiffness.
Xanax withdrawal - Hepatic Enzymes Increased - An increase in the amount of paired liver proteins that regulate liver processes causing a condition where the liver functions abnormally.
Xanax withdrawal - Hypercholesterolemia - Too much cholesterol in the blood cells.
Xanax withdrawal - Hyperglycemia - An unhealthy amount of sugar in the blood.
Xanax withdrawal - Increased Weight - A concentration and storage of fat in the body accumulating over a period of time caused by unhealthy eating patterns, that can predispose the body to many disorders and diseases.
Xanax withdrawal - Jaw Pain - The pain due to irritation and swelling of the nerves associated with the mouth area where it opens and closes just in front of the ear. Some of the symptoms are pain when chewing, head aches, losing your balance, stuffy ears or ringing in the ears, and teeth grinding.
Xanax withdrawal - Jaw Stiffness - The result of squeezing and grinding the teeth while asleep that can cause your teeth to deteriorate as well as the muscles and joints of the jaw.
Xanax withdrawal - Joint Stiffness - A loss of free motion and easy flexibility where any two bones come together.
Xanax withdrawal - Muscle Cramp - When muscles contract uncontrollably without warning and do not relax. The muscles of any of the body’s organs can cramp.
Xanax withdrawal - Muscle Stiffness - Tightening of muscles making it difficult to bend.
Xanax withdrawal - Muscle Weakness - Loss of physical strength.
Xanax withdrawal - Myalgia - A general widespread pain and tenderness of the muscles.
Xanax withdrawal - Thirst - A strong, unnatural craving for moisture/water in the mouth and throat.
Xanax withdrawal - Nervous System (Sensory channels)
Xanax withdrawal - Carpal Tunnel Syndrome - A pinched nerve in the wrist that causes pain, tingling, and numbing.
Xanax withdrawal - Coordination Abnormal - A lack of normal, harmonious interaction of the parts of the body when it is in motion.
Xanax withdrawal - Dizziness - Losing one’s balance while feeling unsteady and lightheaded which may lead to fainting.
Xanax withdrawal - Disequilibrium - Lack of mental and emotional balance.
Xanax withdrawal - Faintness - A temporary condition where one is likely to go unconscious and fall.
Xanax withdrawal - Headache - A sharp or dull persistent pain in the head
Xanax withdrawal - Hyperreflexia - A not normal and involuntary increased response in the tissues connecting the bones to the muscles.
Xanax withdrawal - Light-headed Feeling – Uncontrolled and usually brief loss of consciousness caused by lack of oxygen to the brain.
Xanax withdrawal - Migraine - Reoccurring severe head pain usually with nausea, vomiting, dizziness, flashes or spots before the eyes, and ringing in the ears
Xanax withdrawal - Muscle Contractions Involuntary - Spontaneous and uncontrollable tightening reaction of the muscles caused by electrical impulses from the nervous system.
Xanax withdrawal - Muscular Tone Increased - Uncontrolled and exaggeration muscle tension. Muscles are normally partially tensed and this is what gives us muscle tone.
Xanax withdrawal - Paresthesia - Burning, prickly, itchy, or tingling skin with no obvious or understood physical cause.
Xanax withdrawal - Restless Legs - A need to move the legs without any apparent reason. Sometimes there is pain, twitching, jerking, cramping, burning, or a creepy-crawly sensation associated with the movements. It worsens when a person is inactive and can interrupt one’s sleep so one feels the need to move to gain some relief.
Xanax withdrawal - Shaking - Uncontrolled quivering and trembling as if one is cold and chilled.
Xanax withdrawal - Sluggishness - Lack of alertness and energy, as well as being slow to respond or perform in life.
Xanax withdrawal - Tics - A contraction of a muscle causing a repeated movement not under the control of the person usually on the face or limbs.
Xanax withdrawal - Tremor - A nervous and involuntary vibrating or quivering of the body.
Xanax withdrawal - Twitching - Sharp, jerky and spastic motion sometimes with a sharp sudden pain.
Xanax withdrawal - Vertigo - A sensation of dizziness with disorientation and confusion.
Xanax withdrawal - Psychiatric Disorders (Mental and emotional)
Xanax withdrawal - Aggravated Nervousness - A progressively worsening, irritated and troubled state of mind.
Xanax withdrawal - Agitation - Suddenly violent and forceful, emotionally disturbed state of mind.
Xanax withdrawal - Amnesia - Long term or short term, partial or full memory loss created by emotional or physical shock, severe illness, or a blow to the head where the person was caused pain and became unconsciousness.
Xanax withdrawal - Anxiety Attack - Sudden and intense feelings of fear, terror, and dread physically creating shortness of breath, sweating, trembling and heart palpitations.
Xanax withdrawal - Apathy - Complete lack of concern or interest for things that ordinarily would be regarded as important or would normally cause concern.
Xanax withdrawal - Appetite Decreased - Having a lack of appetite despite the ordinary caloric demands of living with a resulting unintentional loss of weight.
Xanax withdrawal - Appetite Increased - An unusual hunger causing one to overeat.
Xanax withdrawal - Auditory Hallucination - Hearing things without the voices or noises being present.
Xanax withdrawal - Bruxism - Grinding and clenching of teeth while sleeping.
Xanax withdrawal - Carbohydrate Craving - A drive and craving to eat foods rich in sugar and starches (sweets, snacks and junk foods) that intensifies as the diet becomes more and more unbalanced due to the unbalancing of the proper nutritional requirements of the body.
Xanax withdrawal - Concentration Impaired - Unable to easily focus your attention for long periods of time.
Xanax withdrawal - Confusion - Not able to think clearly and understand in order to make a logical decision.
Xanax withdrawal - Crying Abnormal - Unusual and not normal fits of weeping for short or long periods of time for no apparent reason.
Xanax withdrawal - Depersonalization - A condition where one has lost a normal sense of personal identity.
Xanax withdrawal - Depression - A hopeless feeling of failure, loss and sadness that can deteriorate into thoughts of death.
Xanax withdrawal - Disorientation - A loss of sense of direction, place, time or surroundings as well as mental confusion on personal identity.
Xanax withdrawal - Dreaming Abnormal - Dreaming that leaves a very clear, detailed picture and impression when awake that can last for a long period of time and sometimes be unpleasant.
Xanax withdrawal - Emotional Lability - Suddenly breaking out in laughter or crying or doing both without being able to control the outburst of emotion. These episodes are unstable as they are caused by things that normally would not have this effect on an individual.
Xanax withdrawal - Excitability - Uncontrollably responding to stimuli.
Xanax withdrawal - Feeling Unreal - The awareness that one has an undesirable emotion like fear but can’t seem to shake off the irrational feeling. For example, feeling like one is going crazy but rationally knowing that it is not true. The quality of this side effect resembles being in a bad dream and not being able to wake up.
Xanax withdrawal - Forgetfulness - Unable to remember what one ordinarily would remember.
Xanax withdrawal - Insomnia - Sleeplessness caused by physical stress, mental stress or stimulants such as coffee or medications; it is a condition of being abnormally awake when one would ordinarily be able to fall and remain asleep.
Xanax withdrawal - Irritability - Abnormally annoyed in response to a stimulus.
Xanax withdrawal - Jitteriness - Nervous fidgeting without an apparent cause.
Xanax withdrawal - Lethargy - Mental and physical sluggishness and apathy that can deteriorate into an unconscious state resembling deep sleep. A numbed state of mind.
Xanax withdrawal - Libido Decreased - An abnormal loss of sexual energy or desire.
Xanax withdrawal - Panic Reaction - A sudden, overpowering, chaotic and confused mental state of terror resulting in being doubt ridden often accompanied with hyperventilation, and extreme anxiety.
Xanax withdrawal - Restlessness Aggravated - A constantly worsening troubled state of mind characterized by the person being increasingly nervous, unable to relax, and easily angered.
Xanax withdrawal - Somnolence - Feeling sleepy all the time or having a condition of semi-consciousness.
Xanax withdrawal - Suicide Attempt - An unsuccessful deliberate attack on one’s own life with the intention of ending it.
Xanax withdrawal - Suicidal Tendency - Most likely will attempt to kill oneself.
Xanax withdrawal - Tremulousness Nervous - Very jumpy, shaky, and uneasy while feeling fearful and timid. The condition is characterized by thoughts of dreading the future, involuntary quivering, trembling, and feeling distressed and suddenly upset.
Xanax withdrawal - Yawning - involuntary opening of the mouth with deep inhalation of air.
Xanax withdrawal - Reproductive Disorder Female
Xanax withdrawal - Breast Neoplasm - A tumor or cancer, of either of the two milk-secreting organs on the chest of a woman.
Xanax withdrawal - Menorrhagia - Abnormally heavy menstrual period or a menstrual flow that has continued for an unusually long period of time.
Xanax withdrawal - Menstrual Cramps - Painful, involuntary uterus contractions that women experience around the time of their menstrual period, sometimes causing pain in the lower back and thighs.
Xanax withdrawal - Menstrual Disorder - A disturbance or derangement in the normal function of a woman’s menstrual period.
Xanax withdrawal - Pelvic Inflammation - The reaction of the body to infectious, allergic, or chemical irritation, which in turn causes tissue irritation, injury, or bacterial infection characterized by pain, redness, swelling, and sometimes loss of function. The reaction usually begins in the uterus and spreads to the fallopian tubes, ovaries, and other areas in the hipbone region of the body.
Xanax withdrawal - Premenstrual Syndrome - Various physical and mental symptoms commonly experienced by women of childbearing age usually 2 to 7 days before the start of their monthly period. There are over 150 symptoms including eating binges, behavioral changes, moodiness, irritability, fatigue, fluid retention, breast tenderness, headaches, bloating, anxiety, and depression. The symptoms cease shortly after the period begins, and disappear with menopause.
Xanax withdrawal - Spotting Between Menses - Abnormal bleeding between periods. Unusual spotting between menstrual cycles.
Xanax withdrawal - RESPIRATORY SYSTEM (Organs involved in breathing)
Xanax withdrawal - Asthma - A disease of the breathing system initiated by and allergic reaction or a chemical with repeated attacks of coughing, sticky mucus, wheezing, shortness of breath, and a tight feeling in the chest. The disease can reach a state where it stops a person from exhaling, leading to unconsciousness and death.
Xanax withdrawal - Breath Shortness - Unnatural breathing using a lot off effort resulting in not enough air taken in by the body.
Xanax withdrawal - Bronchitis - Inflammation of the two main breathing tubes leading from the windpipe to the lungs. The disease is marked with coughing, a low-grade fever, chest pains, and hoarseness, caused by an allergic reaction.
Xanax withdrawal - Coughing - A cough is the response to an irritation, such as mucus, that causes the muscles controlling the breathing process to expel air from the lungs suddenly and noisily to keep the air passages free from the irritating material.
Xanax withdrawal - Laryngitis - Inflammation of the voice box characterized by hoarseness, sore throat, and coughing. It can be cause by straining the voice or exposure to infectious, allergic or chemical irritation.
Xanax withdrawal - Nasal Congestion - The presence of an abnormal amount of fluid in the nose.
Xanax withdrawal - Pneumonia Tracheitis - Bacterial infection of the air passageways and lungs that causes redness, swelling and pain in the windpipe. Other symptoms are high fever, chills, pain in the chest, difficulty in breathing, and coughing with mucus discharge.
Xanax withdrawal - Rhinitis - Chemical irritation causing pain, redness and swelling in the mucus membranes of the nose.
Xanax withdrawal - Sinus Congestion - The mucus-lined areas of the bones in the face that are thought to help warm and moisten air to the nose. These areas become clogged with excess fluid or infected.
Xanax withdrawal - Sinus Headache - The abnormal amount of fluid in the hollows of the face bone area especially around the nose. This excess fluid creates pressure, causing pain in the head.
Xanax withdrawal - Sinusitis - The body reacting to chemical irritation causing redness, swelling and pain in the area of the hollows in the facial bones especially around the nose.
Xanax withdrawal - SKELETAL
Xanax withdrawal - Neck/Shoulder Pain - Hurtful sensations of the nerve endings caused by damage to the tissues in the neck and shoulder signaling danger of disease.
Xanax withdrawal - SKIN and APPENDAGES DISORDERS (Skin, legs and arms)
Xanax withdrawal - Acne - Eruptions of the oils glands of the skin, especially on the face, marked by pimples, blackheads, whiteheads, bumps, and more severely, by cysts and scarring.
Xanax withdrawal - Alopecia - The loss of hair or baldness.
Xanax withdrawal - Eczema - A severe or continuing skin disease marked by redness, crusting and scaling with watery blisters and itching. It is often difficult to treat and will sometimes go away only to reappear again.
Xanax withdrawal - Dermatitis - Generally irritated skin that can be caused by any of a number of irritating things such as parasites, fungus, bacteria, or foreign substances causing an allergic reaction. It is a general inflammation of the skin.
Xanax withdrawal - Dry Lips - The lack of normal moisture in the fleshy folds that surround the mouth.
Xanax withdrawal - Dry Skin - The lack of normal moisture/oils in the surface layer of the body. The skin is the body’s largest organ.
Xanax withdrawal - Folliculitis - Inflammation of a follicle (small body sac) especially a hair follicle. A hair follicle contains the root of a hair.
Xanax withdrawal - Furunculosis - Skin boils that show up repeatedly.
Xanax withdrawal - Lipoma - A tumor of mostly fat cells that is not health endangering.
Xanax withdrawal - Pruritus - Extreme itching of often-undamaged skin.
Xanax withdrawal - Rash - A skin eruption or discoloration that may or may not be itching, tingling, burning, or painful. It may be caused by an allergy, an skin irritation, a skin disease.
Xanax withdrawal - Skin Nodule - A bulge, knob, swelling or outgrowth in the skin that is a mass of tissue or cells.
Xanax withdrawal - SPECIAL SENSES
Xanax withdrawal - Conjunctivitis - Infection of the membrane that covers the eyeball and lines the eyelid, caused by a virus, allergic reaction, or an irritating chemical. It is characterized by redness, a discharge of fluid and itching.
Xanax withdrawal - Dry Eyes - Not enough moisture in the eyes.
Xanax withdrawal - Earache - Pain in the ear.
Xanax withdrawal - Eye Infection - The invasion of the eye tissue by a bacteria, virus, fungus, etc, causing damage to the tissue, with toxicity. Infection spreading in the body progresses into disease.
Xanax withdrawal - Eye Irritation - An inflammation of the eye.
Xanax withdrawal - Metallic Taste - A range of taste impairment from distorted taste to a complete loss of taste.
Xanax withdrawal - Pupils Dilated - Abnormal expansion of the blace circular opening in the center of the eye.
Xanax withdrawal - Taste alteration - Abnormal flavor detection in food.
Xanax withdrawal - Tinnitus - A buzzing, ringing, or whistling sound in one or both ears occurring from the internal use of certain drugs.
Xanax withdrawal - Vision Abnormal - Normal images are seen differently by the viewer.
Xanax withdrawal - Vision Blurred - Eyesight is dim or indistinct and hazy in outline or appearance.
Xanax withdrawal - Visual Disturbance - Eyesight is interfered with or interrupted. Some disturbances are light sensitivity and the inability to easily distinguish colors.
Xanax withdrawal - URINARY SYSTEM DISORDER
Xanax withdrawal - Blood in Urine - Blood is present when one empties liquid waste product of the kidneys through the bladder by urinating in the toilet turning the water pink to bright red. Or you could see pots of blood in the water after urinating.
Xanax withdrawal - Dysuria - Difficult or painful urination.
Xanax withdrawal - Kidney Stone - Small hard masses of salt deposits that the kidney forms.
Xanax withdrawal - Urinary Frequency - Having to urinate more often than usual or between unusually short time periods.
Xanax withdrawal - Urinary Tract Infection - An invasion of bacteria, viruses, fungi, etc., of the system in the body that starts with the kidneys and eliminates urine from the body. If the invasion goes unchecked it can injure tissue and progress into disease.
Xanax withdrawal - Urinary Urgency - A sudden compelling urge to urinate, accompanied by discomfort in the bladder.
Xanax withdrawal - UROGENITAL (Urinary tract and genital structures or functions)
Xanax withdrawal - Anorgasmia - Failure to experience an orgasm.
Xanax withdrawal - Ejaculation Disorder - Dysfunction of the discharge of semen during orgasm.
Xanax withdrawal - Menstrual Disorder - Dysfunction of the discharge during the monthly menstrual cycle.
Xanax withdrawal - Acute Renal Failure - The kidneys stop functioning properly to excrete wastes.
Xanax withdrawal - Angioedema - Intensely itching and swelling welts on the skin called hives caused by an allergic reaction to internal or external agents. The reaction is common to a food or a drug. Chronic cases can last for a long period of time.
Xanax withdrawal - Toxic Epidermal Necrolysis - An abnormal condition where a large portion of skin becomes intensely red and peels off like a second-degree burn. Often the symptoms include blistering.
Xanax withdrawal - Gastrointestinal Hemorrhage - Stomach and intestinal excessive internal bleeding.
Xanax withdrawal - Grand Mal Seizures (or Convulsions) - A recurring sudden violent and involuntary attack of muscle spasms with a loss of consciousness.
Xanax withdrawal - Neuroleptic Malignant Syndrome - A life threatening, rare reaction to an anti-psychotic drug marked by fever, muscular rigidity, changed mental status, and dysfunction of the autonomic nervous system.
Xanax withdrawal - Pancreatitis - Chemical irritation with redness, swelling, and pain in the pancreas where digestive enzymes and hormones are secreted.
Xanax withdrawal - QT Prolongation - A very fast heart rhythm disturbance that is too fast for the heart to beat effectively so the blood to the brain falls causing a sudden loss of consciousness and may cause sudden cardiac death.
Xanax withdrawal - Rhabdomyolysis - The breakdown of muscle fibers that releases the fibers into the circulatory system. Some of the fibers are poisonous to the kidney and frequently result in kidney damage.
Xanax withdrawal - Serotonin Syndrome - A disorder brought on by excessive levels of serotonin caused by drugs and can be fatal as death from this side effect can come very rapidly.
Xanax withdrawal - Thrombocytopenia - An abnormal decrease in the number of blood platelets in the circulatory system. A decrease in platelets would cause a decrease in the ability of the blood to clot when necessary.
Xanax withdrawal - Torsades de Pointes - Unusual rapid heart rhythm starting in the lower heart chambers. If the short bursts of rapid heart rhythm continue for a prolonged period it can degenerate into a more rapid rhythm and can be fatal.
Xanax Clinical Trials
Fenneteau F, Poulin P, Nekka F.
J Pharm Sci. 2009 May 28. [Epub ahead of print]
PMID: 19479982 [Xanax - as supplied
by publisher]
A fatal case of benzodiazepine withdrawal.
Lann MA, Molina DK.
Am J Forensic Med Pathol. 2009 Jun;30(2):177-9.
PMID: 19465812 [Xanax - in process]
Pallier PN, Morton AJ.
Brain Res. 2009 May 18. [Epub ahead of print]
PMID: 19450569 [Xanax - as supplied
by publisher]
Poisnel G, Dhilly M, Boisselier RL, Barre L,
Debruyne D.
J Pharmacol Sci. 2009 May;110(1):36-46.
PMID: 19443999 [Xanax - in process]
Related Articles
Free article at journal site
Feltner D, Hill C, Lenderking W, Williams V,
Morlock R.
J Psychiatr Res. 2009 May 5. [Epub ahead of print]
PMID: 19423131 [Xanax - as supplied
by publisher]
Baas JM, Mol N, Kenemans JL, Prinssen EP, Niklson
I, Xia-Chen C, Broeyer F, van Gerven J.
Psychopharmacology (Berl). 2009 May 5. [Epub ahead
of print]
PMID: 19415242 [Xanax - as supplied
by publisher]
Multiple drug ingestion by ecstasy abusers in the
United States.
Black DL, Cawthon B, Robert T, Moser F, Caplan YH,
Cone EJ.
J Anal Toxicol. 2009 Apr;33(3):143-7.
PMID: 19371462 [Xanax - in process]
Ogren PJ, Meetze A, Duer WC.
J Anal Toxicol. 2009 Apr;33(3):129-42.
PMID: 19371461 [Xanax - in process]
Stein DJ, Bruce Lydiard R, Herman BK, Mandel FS.
Int Clin Psychopharmacol. 2009 May;24(3):126-32.
PMID: 19352198 [Xanax - in process]
Nanostructure initiator mass spectrometry: tissue
imaging and direct biofluid analysis.
Yanes O, Woo HK, Northen TR, Oppenheimer SR,
Shriver L, Apon J, Estrada MN, Potchoiba MJ, Steenwyk R, Manchester M, Siuzdak
G.
Anal Chem. 2009 Apr 15;81(8):2969-75.
PMID: 19301920 [Xanax - in process]
Related Articles
Free article in PMC | at journal site
Adverse effects of benzodiazepines in psychiatric
outpatients.
Arbanas G, Arbanas D, Dujam K.
Psychiatr Danub. 2009 Mar;21(1):103-7.
PMID: 19270632 [Xanax - indexed for
MEDLINE]
Psychotropic drug prescribing in the family medicine
out-patient clinic, Ramathibodi Hospital.
Prueksaritanond S, Tubtimtes S, Pumkompol T,
Sukying C.
J Med Assoc Thai. 2009 Feb;92(2):266-72.
PMID: 19253804 [Xanax - indexed for
MEDLINE]
Five deaths resulting from abuse of dextromethorphan
sold over the internet.
Logan BK, Goldfogel G, Hamilton R, Kuhlman J.
J Anal Toxicol. 2009 Mar;33(2):99-103.
PMID: 19239735 [Xanax - indexed for
MEDLINE]
Sugahara H, Maebara C, Ohtani H, Handa M, Ando K,
Mine K, Kubo C, Ieiri I, Sawada Y.
Eur J Clin Pharmacol. 2009 Feb 19. [Epub ahead of
print]
PMID: 19225771 [Xanax - as supplied
by publisher]
Successful treatment of chronic drug-resistant
urticaria with alprazolam.
Dueñas-Laita A, Ruiz-Muñoz P, Armentia A, Pinacho
F, Martín-Armentia B.
J Allergy Clin Immunol. 2009 Feb;123(2):504-5. No
abstract available.
PMID: 19203665 [Xanax - indexed for
MEDLINE]
Pathak A, Rajput SJ.
J AOAC Int. 2008 Nov-Dec;91(6):1344-53.
PMID: 19202795 [Xanax - indexed for
MEDLINE]
Deme D, Al-Hadad A, Varga T, Szántó E, Sándor K,
Rakonczai E.
Orv Hetil. 2009 Feb 8;150(6):265-9. Hungarian.
PMID: 19179259 [Xanax - indexed for
MEDLINE]
Matar MA, Zohar J, Kaplan Z, Cohen H.
Eur Neuropsychopharmacol. 2009 Apr;19(4):283-95.
Epub 2009 Jan 23.
PMID: 19167197 [Xanax - indexed for
MEDLINE]
Lonergan E, Luxenberg J, Areosa Sastre A, Wyller
TB.
Cochrane Database Syst Rev. 2009 Jan
21;(1):CD006379. Review.
PMID: 19160280 [Xanax - indexed for
MEDLINE]
[Observation on the therapeutic effect of neck
clustered needling on insomnia]
Qi LZ, Ma XP, Yang L.
Zhongguo Zhen Jiu. 2008 Dec;28(12):861-4. Chinese.
PMID: 19127908 [Xanax - indexed for
MEDLINE]
Non-fearful panic disorder in gastroenterology.
Porcelli P, De Carne M.
Psychosomatics. 2008 Nov-Dec;49(6):543-5.
PMID: 19122134 [Xanax - indexed for
MEDLINE]
Marchi I, Schappler J, Veuthey JL, Rudaz S.
J Chromatogr B Analyt Technol Biomed Life Sci. 2008
Dec 6. [Epub ahead of print]
PMID: 19110476 [Xanax - as supplied
by publisher]
Alprazolam intercalates into DNA.
Saha B, Mukherjee A, Santra CR, Chattopadhyay A,
Ghosh AN, Choudhuri U, Karmakar P.
J Biomol Struct Dyn. 2009 Feb;26(4):421-9.
PMID: 19108581 [Xanax - in process]
Huidobro AL, Barbas C.
Anal Bioanal Chem. 2008 Dec 10. [Epub ahead of
print]
PMID: 19066862 [Xanax - as supplied
by publisher]
Foreman MM, Hanania T, Eller M.
Eur J Pharmacol. 2009 Jan 14;602(2-3):316-20. Epub
2008 Nov 17.
PMID: 19038245 [Xanax - indexed for
MEDLINE]
Licata SC, Platt DM, Cook JM, Van Linn ML, Rowlett
JK.
Psychopharmacology (Berl). 2009 Apr;203(3):539-46.
Epub 2008 Nov 25.
PMID: 19031072 [Xanax - in process]
Tiscione NB, Shan X, Alford I, Yeatman DT.
J Anal Toxicol. 2008 Oct;32(8):644-52.
PMID: 19007516 [Xanax - indexed for
MEDLINE]
Comparison of drug concentrations taken from clamped
and unclamped femoral vessels.
Hargrove VM, McCutcheon JR.
J Anal Toxicol. 2008 Oct;32(8):621-5.
PMID: 19007512 [Xanax - indexed for
MEDLINE]
Clinical observation on post-stroke anxiety neurosis
treated by acupuncture.
Wu P, Liu S.
J Tradit Chin Med. 2008 Sep;28(3):186-8.
PMID: 19004200 [Xanax - indexed for
MEDLINE]
Uddin MN, Samanidou VF, Papadoyannis IN.
J Sep Sci. 2008 Dec;31(21):3704-17.
PMID: 19003810 [Xanax - indexed for
MEDLINE]
Maresova V, Chadt J, Novakova E.
Neuro Endocrinol Lett. 2008 Oct;29(5):749-54.
PMID: 18987582 [Xanax - indexed for
MEDLINE]
Bogaert GA, Trouet D, Bernaerts J, Luysmans P,
Evers G, Wille M.
J Pediatr Urol. 2005 Apr;1(2):61-8.
PMID: 18947538 [Xanax - in process]
Lebanese turn to drugs to treat mental-health
problems.
Solberg KE.
Lancet. 2008 Sep 27;372(9644):1137-8. No abstract
available.
PMID: 18942175 [Xanax - indexed for
MEDLINE]
Nakamura M, Ohmori T, Itoh Y, Terashita M, Hirano
K.
Biomed Chromatogr. 2009 Apr;23(4):357-64.
PMID: 18937304 [Xanax - in process]
Koçak A, Berets SL.
Appl Spectrosc. 2008 Jul;62(7):803-9.
PMID: 18935832 [Xanax - indexed for
MEDLINE]
Benzodiazepine metabolism: an analytical
perspective.
Mandrioli R, Mercolini L, Raggi MA.
Curr Drug Metab. 2008 Oct;9(8):827-44. Review.
PMID: 18855614 [Xanax - indexed for
MEDLINE]
A probable case of gabapentin-related reversible
hearing loss in a patient with acute renal failure.
Pierce DA, Holt SR, Reeves-Daniel A.
Clin Ther. 2008 Sep;30(9):1681-4.
PMID: 18840374 [Xanax - indexed for
MEDLINE]
Gidai J, Acs N, Bánhidy F, Czeizel AE.
Toxicol Ind Health. 2008 Feb-Mar;24(1-2):53-60.
PMID: 18818181 [Xanax - indexed for
MEDLINE]
Alprazolam and oxazepam block the cue-induced
reinstatement of extinguished cocaine seeking in rats.
Goeders NE, Clampitt DM, Keller C, Sharma M, Guerin
GF.
Psychopharmacology (Berl). 2009 Jan;201(4):581-8.
Epub 2008 Sep 17.
PMID: 18797849 [Xanax - indexed for
MEDLINE]
Quantitation of benzodiazepines in urine, serum,
plasma, and meconium by LC-MS-MS.
Marin SJ, Coles R, Merrell M, McMillin GA.
J Anal Toxicol. 2008 Sep;32(7):491-8.
PMID: 18713517 [Xanax - indexed for
MEDLINE]
Sedative-hypnotic medication exposures and
poisonings in Izmir,Turkey.
Oray NC, Hocaoglu N, Oray D, Demir O, Atilla R,
Tuncok Y.
Basic Clin Pharmacol Toxicol. 2008
Oct;103(4):380-5.
PMID: 18699798 [Xanax - indexed for
MEDLINE]
Hsieh CY, Chen CH.
Clin Ther. 2008 Jul;30(7):1330-5.
PMID: 18691993 [Xanax - indexed for
MEDLINE]
Clinical drugs that interact with St. John's wort
and implication in drug development.
Di YM, Li CG, Xue CC, Zhou SF.
Curr Pharm Des. 2008;14(17):1723-42. Review.
PMID: 18673195 [Xanax - indexed for
MEDLINE]
Alonso-Navarro H, Fernández-Díaz A, Martín-Prieto
M, Ruiz-Ezquerro JJ, López-Alburquerque T, Jiménez-Jiménez FJ.
Clin Neuropharmacol. 2008 Jul-Aug;31(4):241-4.
PMID: 18670249 [Xanax - indexed for
MEDLINE]
Drug testing in oral fluid-evaluation of sample
collection devices.
Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi
K, Lillsunde P.
J Anal Toxicol. 2008 Jul-Aug;32(6):393-401.
PMID: 18652744 [Xanax - indexed for
MEDLINE]
Nutt D, Mandel F, Baldinetti F.
J Psychopharmacol. 2008 Jul 17. [Epub ahead of
print]
PMID: 18635690 [Xanax - as supplied
by publisher]
Zhong ZG, Cai H, Li XL, Lü D.
Zhongguo Zhen Jiu. 2008 Jun;28(6):411-3. Chinese.
PMID: 18630537 [Xanax - indexed for
MEDLINE]
Atypical depression as a premonitory symptom of
migraine managed by an oral contraceptive.
Kawamura S, Sakai A, Endo T, Maruta M.
Psychiatry Clin Neurosci. 2008 Jun;62(3):365. No
abstract available.
PMID: 18588602 [Xanax - indexed for
MEDLINE]
Does oral alprazolam affect ventilation? A
randomised, double-blind, placebo-controlled trial.
Carraro G, Russi E, Buechi S, Bloch K.
J Psychopharmacol. 2009 May;23(3):322-7. Epub 2008
Jun 18.
PMID: 18562435 [Xanax - in process]
Bailey JE, Papadopoulos A, Seddon K, Nutt DJ.
J Psychopharmacol. 2009 Mar;23(2):117-22. Epub 2008
Jun 18.
PMID: 18562427 [Xanax - in process]
Agarwal V, Kommaddi RP, Valli K, Ryder D, Hyde TM,
Kleinman JE, Strobel HW, Ravindranath V.
PLoS ONE. 2008 Jun 11;3(6):e2337.
PMID: 18545703 [Xanax - indexed for
MEDLINE]
Related Articles
Free article in PMC | at journal site
Drug screening of hair by liquid
chromatography-tandem mass spectrometry.
Hegstad S, Khiabani HZ, Kristoffersen L, Kunøe N,
Lobmaier PP, Christophersen AS.
J Anal Toxicol. 2008 Jun;32(5):364-72.
PMID: 18544222 [Xanax - indexed for
MEDLINE]
Stress-induced attenuation of acoustic startle in
low-saccharin-consuming rats.
Gonzales M, Garrett C, Chapman CD, Dess NK.
Biol Psychol. 2008 Oct;79(2):193-9. Epub 2008 May
3.
PMID: 18538914 [Xanax - indexed for
MEDLINE]
[Long-term effectiveness of an intervention to
discontinue chronic benzodiazepine use]
Vicens Caldentey C, Fiol Gelabert F, González
Garrido E, Martínez Ojeda E, Mateu Sabater C, Llobera Cánaves J.
Actas Esp Psiquiatr. 2008 Sep-Oct;36(5):295-8.
Spanish.
PMID: 18523893 [Xanax - indexed for
MEDLINE]
Related Articles
Free article at journal site
Zuckschwerdt JB, Nixon CE, Ciner FL, Croley TR.
J Food Prot. 2008 May;71(5):1007-14.
PMID: 18522037 [Xanax - indexed for
MEDLINE]
[Anxiety level and addiction to first-time
prescriptions of anxiolytics: a psychometric study]
Barthelmé B, Poirot Y.
Presse Med. 2008 Nov;37(11):1555-60. Epub 2008 May
23. French.
PMID: 18502091 [Xanax - indexed for
MEDLINE]
Sila-on W, Vardhanabhuti N, Ongpipattanakul B,
Kulvanich P.
AAPS PharmSciTech. 2008;9(2):684-92. Epub 2008 May
22.
PMID: 18496755 [Xanax - indexed for
MEDLINE]
Bailey JE, Nutt DJ.
Pharmacol Biochem Behav. 2008 Jul;90(1):51-7. Epub
2008 Apr 9. Review.
PMID: 18485466 [Xanax - indexed for
MEDLINE]
Concheiro M, de Castro A, Quintela O, Cruz A,
López-Rivadulla M.
Anal Bioanal Chem. 2008 Jul;391(6):2329-38. Epub
2008 May 16.
PMID: 18483722 [Xanax - indexed for
MEDLINE]
Citalopram-associated spontaneous ejaculations.
Virit O, Savas HA.
J Clin Psychopharmacol. 2008 Jun;28(3):360-1. No
abstract available.
PMID: 18480704 [Xanax - indexed for
MEDLINE]
Complete atrioventricular block associated with
concomitant use of metoprolol and paroxetine.
Onalan O, Cumurcu BE, Bekar L.
Mayo Clin Proc. 2008 May;83(5):595-9.
PMID: 18452693 [Xanax - indexed for
MEDLINE]
Related Articles
Free article at journal site
de Bortoli VC, Nogueira RL, Zangrossi H Jr.
Psychopharmacology (Berl). 2008 Jun;198(3):341-9.
Epub 2008 Apr 30.
PMID: 18446327 [Xanax - indexed for
MEDLINE]
Akatova EV, Sukhanova ED, Mel'nik OO, Martynov AI.
Klin Med (Mosk). 2008;86(3):55-8. Russian.
PMID: 18441707 [Xanax - indexed for
MEDLINE]
Koval'chuk VV.
Vopr Onkol. 2007;53(6):704-10. Russian. No abstract
available.
PMID: 18416142 [Xanax - indexed for
MEDLINE]
Huidobro AL, Pruim P, Schoenmakers P, Barbas C.
J Chromatogr A. 2008 May 9;1190(1-2):182-90. Epub
2008 Mar 13.
PMID: 18400227 [Xanax - indexed for
MEDLINE]
Lu C, Hatsis P, Berg C, Lee FW, Balani SK.
Drug Metab Dispos. 2008 Jul;36(7):1255-60. Epub
2008 Apr 1.
PMID: 18381489 [Xanax - indexed for
MEDLINE]
Peters RJ Jr, Meshack AF, Kelder SH, Webb P, Smith
D, Garner K.
J Drug Educ. 2007;37(4):417-28.
PMID: 18351180 [Xanax - indexed for
MEDLINE]
Hallifax D, Galetin A, Houston JB.
Xenobiotica. 2008 Apr;38(4):353-67.
PMID: 18340561 [Xanax - indexed for
MEDLINE]
Pharmacology of neuropeptide S in mice: therapeutic
relevance to anxiety disorders.
Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B,
Logue SF, Neal SJ, Malberg JE, Beyer CE, Schechter LE, Rosenzweig-Lipson S, Ring
RH.
Psychopharmacology (Berl). 2008 May;197(4):601-11.
Epub 2008 Mar 3.
PMID: 18311561 [Xanax - indexed for
MEDLINE]
Abraham PF, Calabrese JR.
J Affect Disord. 2008 Nov;111(1):21-30. Epub 2008
Mar 4. Review.
PMID: 18304647 [Xanax - indexed for
MEDLINE]
Tsavaris N, Kosmas C, Kopterides P, Vadiaka M,
Kosmas N, Skopelitis H, Karadima D, Kolliokosta G, Tzima E, Loukeris D, Pagouni
E, Batziou E, Xyla V, Koufos C.
Eur J Cancer Care (Engl). 2008 Mar;17(2):167-73.
PMID: 18302654 [Xanax - indexed for
MEDLINE]
Singh A, Kumar A.
Neurosci Res. 2008 Apr;60(4):372-9. Epub 2007 Dec
23.
PMID: 18280601 [Xanax - indexed for
MEDLINE]
Zhu YJ, Liu ZY, Chen Y, Zheng P, Zhu JH, Tao QM,
Zheng LR, Wang QQ, Shi MJ, Qiu YG.
Zhonghua Xin Xue Guan Bing Za Zhi. 2007
Oct;35(10):919-22. Chinese.
PMID: 18206039 [Xanax - in process]
The quality of hemodialysis in patients with mental
retardation.
Weng CH, Yen TH, Chen KH, Hung CC, Wu JH, Yang CW,
Chang CT.
Ren Fail. 2008;30(1):63-5.
PMID: 18197545 [Xanax - indexed for
MEDLINE]
Yuan Q, Li JN, Liu B, Wu ZF, Jin R.
Chin J Integr Med. 2007 Dec;13(4):264-8.
PMID: 18180890 [Xanax - indexed for
MEDLINE]
Depression, anxiety and substance use in medical
students in the Republic of Macedonia.
Mancevska S, Bozinovska L, Tecce J,
Pluncevik-Gligoroska J, Sivevska-Smilevska E.
Bratisl Lek Listy. 2008;109(12):568-72.
PMID: 19348380 [Xanax - indexed for
MEDLINE]
Mills KC, Drazkowski JF, Hammer AE, Caldwell PT,
Kustra RP, Blum DE.
Epilepsy Res. 2008 Feb;78(2-3):140-6. Epub 2007 Dec
21.
PMID: 18155445 [Xanax - indexed for
MEDLINE]
Determination of benzodiazepines in oral fluid using
LC-MS-MS.
Moore C, Coulter C, Crompton K, Zumwalt M.
J Anal Toxicol. 2007 Nov-Dec;31(9):596-600.
PMID: 18093420 [Xanax - indexed for
MEDLINE]
Loscalzo LM, Wasowski C, Paladini AC, Marder M.
Eur J Pharmacol. 2008 Feb 12;580(3):306-13. Epub
2007 Nov 13.
PMID: 18048026 [Xanax - indexed for
MEDLINE]
Pregabalin in benzodiazepine withdrawal.
Biermann T, Bleich S, Kornhuber J, Hillemacher T.
Pharmacopsychiatry. 2007 Nov;40(6):292-3. No
abstract available.
PMID: 18030656 [Xanax - indexed for
MEDLINE]
Venkateswarlu K, Venisetty RK, Yellu NR, Keshetty
S, Pai MG.
J Chromatogr Sci. 2007 Sep;45(8):537-9.
PMID: 18019565 [Xanax - indexed for
MEDLINE]
Hemoperfusion in the treatment of acute clozapine
intoxication in China.
He JL, Xiang YT, Li WB, Cai ZJ, Ungvari GS.
J Clin Psychopharmacol. 2007 Dec;27(6):667-71.
PMID: 18004134 [Xanax - indexed for
MEDLINE]
Connectivity analysis of EEG under drug therapy.
Alonso JF, Mañanas MA, Romero S, Riba J, Barbanoj
MJ, Hoyer D.
Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6188-91.
PMID: 18003434 [Xanax - indexed for
MEDLINE]
[Therapeutical strategies for essential tremor]
Gironell A.
Med Clin (Barc). 2007 Nov 3;129(16):632-7. Review.
Spanish.
PMID: 18001678 [Xanax - indexed for
MEDLINE]
Predominance of illicit drugs and poly-drug use
among drug-impaired drivers in Sweden.
Holmgren A, Holmgren P, Kugelberg FC, Jones AW,
Ahlner J.
Traffic Inj Prev. 2007 Dec;8(4):361-7.
PMID: 17994489 [Xanax - indexed for
MEDLINE]
An effect-size analysis of pharmacologic treatments
for generalized anxiety disorder.
Hidalgo RB, Tupler LA, Davidson JR.
J Psychopharmacol. 2007 Nov;21(8):864-72.
PMID: 17984162 [Xanax - indexed for
MEDLINE]
Galetin A, Hinton LK, Burt H, Obach RS, Houston JB.
Curr Drug Metab. 2007 Oct;8(7):685-93. Review.
PMID: 17979656 [Xanax - indexed for
MEDLINE]
Fustero S, González J, del Pozo C.
Molecules. 2006 Aug 9;11(8):583-8.
PMID: 17971730 [Xanax - indexed for
MEDLINE]
Cognitive style, alprazolam plasma levels, and
treatment response in panic disorder.
Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ,
Matuzas W, Javaid JI, Barnhill J.
Depress Anxiety. 2008;25(8):E18-26.
PMID: 17960759 [Xanax - indexed for
MEDLINE]
Hermos JA, Young MM, Lawler EV, Rosenbloom D, Fiore
LD.
J Trauma Stress. 2007 Oct;20(5):909-14.
PMID: 17955537 [Xanax - indexed for
MEDLINE]
Metsugi Y, Miyaji Y, Ogawara K, Higaki K, Kimura T.
Pharm Res. 2008 Apr;25(4):886-95. Epub 2007 Oct 23.
PMID: 17955185 [Xanax - indexed for
MEDLINE]
Pregabalin: its efficacy, safety and tolerability
profile in generalized anxiety.
Owen RT.
Drugs Today (Barc). 2007 Sep;43(9):601-10. Review.
PMID: 17940637 [Xanax - indexed for
MEDLINE]
Modulation of human risky decision making by
flunitrazepam.
Lane SD, Cherek DR, Nouvion SO.
Psychopharmacology (Berl). 2008 Feb;196(2):177-88.
Epub 2007 Oct 5.
PMID: 17917718 [Xanax - indexed for
MEDLINE]
Bouchonnet S, Kinani S, Sablier M, Pirnay S.
Eur J Mass Spectrom (Chichester, Eng).
2007;13(3):227-32.
PMID: 17881791 [Xanax - in process]
Bouchonnet S, Kinani S, Sablier M.
Eur J Mass Spectrom (Chichester, Eng).
2007;13(3):223-6.
PMID: 17881790 [Xanax - in process]
Martin JL, Sainz-Pardo M, Furukawa TA,
Martín-Sánchez E, Seoane T, Galán C.
J Psychopharmacol. 2007 Sep;21(7):774-82. Review.
PMID: 17881433 [Xanax - indexed for
MEDLINE]
Barbanoj MJ, Urbano G, Antonijoan R, Ballester MR,
Valle M.
Neuropsychobiology. 2007;55(3-4):203-12. Epub 2007
Sep 17.
PMID: 17878744 [Xanax - indexed for
MEDLINE]
A rapid CZE method for the analysis of
benzodiazepines in spiked beverages.
Webb R, Doble P, Dawson M.
Electrophoresis. 2007 Oct;28(19):3553-65.
PMID: 17853510 [Xanax - indexed for
MEDLINE]
Simultaneous analysis of 14 benzodiazepines in oral
fluid by solid-phase extraction and LC-MS-MS.
Ngwa G, Fritch D, Blum K, Newland G.
J Anal Toxicol. 2007 Sep;31(7):369-76.
PMID: 17725884 [Xanax - indexed for
MEDLINE]
Kauppila TJ, Talaty N, Kuuranne T, Kotiaho T,
Kostiainen R, Cooks RG.
Analyst. 2007 Sep;132(9):868-75. Epub 2007 Jul 10.
PMID: 17710261 [Xanax - indexed for
MEDLINE]
Pharmacology
Anxiolytic - Antipanic
Alprazolam, a triazolo 1,4 benzodiazepine analog, binds with high affinity to the GABA benzodiazepine receptor complex. Considerable evidence suggest that the central pharmacologic/therapeutic actions of alprazolam are mediated via interaction with this receptor complex.
Orally administered it is readily absorbed in man with peak plasma concentrations occurring 1 to 2 hours following administration. The half life range is 6 to 20 hours following single dose administration. With multiple doses, given 3 times daily, steady state is reached within 7 days. Alprazolam and its metabolites are excreted primarily in the urine. Degradation occurs mainly by oxidation yielding the primary and secondary metabolites which are active and appear to have half-lives similar to alprazolam but are present at only low levels in the plasma. Alprazolam is 80% protein bound.
Alprazolam 500 mcg (0.5 mg), administered 3 times a day for 14 days, did not affect prothrombin times or plasma warfarin levels in male volunteers administered sodium warfarin orally.
Indications
For the management of anxiety disorders or the short-term symptomatic relief of symptoms of excessive anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.Alprazolam is indicated for the treatment of Generalized Anxiety Disorder (GAD) and is also indicated for the management of panic disorder with or without agoraphobia.
Back to top of page
Contraindications
Hypersensitivity to alprazolam or other benzodiazepines. Alprazolam is also contraindicated in pregnancy, in infants and in patients with myasthenia gravis and acute narrow angle glaucoma.Warnings
Alprazolam is not recommended for use in patients whose primary diagnosis is psychosis or depression.Occupational Hazards:
As with other CNS depressant drugs, patients should be cautioned against activities requiring mental alertness, judgment and physical coordination such as driving or operating machinery, particularly in the early phases of treatment and until proper adjustment to side effects has been established. Alcohol and benzodiazepines should never
be mixed when driving because of the unpredictable CNS depressant effects of this combination.
Back to top of page
Pregnancy:
Safety in pregnancy has not been established, therefore its use is not recommended. Studies have suggested an increased risk of congenital malformations associated with the use of the benzodiazepines, such as chlordiazepoxide, diazepam, and also meprobamate, during the first trimester of pregnancy. Since alprazolam is a benzodiazepine
derivative, its administration is rarely justified in women of childbearing potential. If the drug is prescribed to a woman of child bearing potential she should be warned to consult her physician regarding the discontinuation of the drug if she intends to become or suspects that she is pregnant.
Lactation:
Back to top of page
Studies in rats have indicated that alprazolam and its metabolites are secreted into the milk. Therefore, nursing should not be undertaken while a patient is receiving the drug.
Safety and efficacy of alprazolam in patients under the age of 18 years has not been established.
Precautions
Elderly and debilitated patients, or those with organic brain syndrome, have been found to be prone to the CNS depressant activity of benzodiazepines even after low doses. Manifestations include ataxia, oversedation and hypotension. Therefore, medication should be administered with caution to these patients, particularly if a drop in blood pressure might lead to cardiac complications. Initial doses should be low and increments should be made gradually, depending on the response of the patient, in order to avoid oversedation, neurological impairment and other possible adverse reactions.Alprazolam should not be administered to individuals prone to drug abuse. Caution should be observed in all patients who are considered to have potential for psychological dependence. Withdrawal symptoms have been observed after abrupt discontinuation of benzodiazepines. These include irritability, nervousness, insomnia, agitation, tremors, convulsions, diarrhea, abdominal cramps, vomiting and mental impairment. Since these symptoms may be similar to those for which the patient is being treated, it may appear that he has suffered a relapse upon discontinuation. It is suggested that alprazolam should be withdrawn gradually if the individual is suspected of having become dependent, or the drug perhaps has been used in prolonged high doses.
Suicidal tendencies may be present in patients with emotional disorders, particularly when depressed and that protective measures and appropriate treatment may be necessary and should be instituted without delay.
Alprazolam should not be used in patients suspected of having psychotic tendencies since excitement and other paradoxical reactions can result from the use of anxiolytic-sedatives in these patients. As with other benzodiazepines, alprazolam should not be used in individuals with physiological anxiety or normal stress of daily living but only in the presence of disabling manifestations of an appropriate pathological anxiety disorder.
These drugs are not effective in patients with characterological and personality disorders or those with obsessive compulsive disorders. Alprazolam is not recommended for the management of depressive or psychotic disorders.
If treatment is necessary in patients with impaired hepatic or renal function, therapy should be initiated at a very low dose and the dosage increased only to the extent that it is compatible with the degree of residual function of these organs.
If alprazolam is administered for repeated cycles of therapy, periodic blood counts and liver function tests are advisable. Back to top of page
Since benzodiazepines may occasionally exacerbate grand mal seizures, caution is required when used in epileptic patients and an adjustment may be necessary in their anticonvulsive medication. Abrupt withdrawal of alprazolam should be avoided.
Benzodiazepines may potentiate or interact with effects of other CNS acting drugs such as alcohol, narcotics, barbiturates, nonbarbiturate hypnotics, antihistamines, phenothiazines, butyrophenones, MAO inhibitors, tricyclic antidepressants and anticonvulsants. Therefore, if alprazolam is to be combined with other drugs acting on the
CNS, careful consideration should be given to the pharmacology of the agent involved because of the possible additive or potentiating effects. Patients should also be advised against the simultaneous use of other CNS depressant drugs and should be cautioned not to take alcohol during the administration of alprazolam.
Adverse Effects Back to top of page
The most frequently reported are drowsiness, coordination difficulties with dizziness. Release of hostility and other paradoxical effects such as irritability, excitability and hallucinations are known to occur with the use of benzodiazepines. Other side effects less frequently reported, listed by body systems, include the following:Neurologic:
Blurred vision, headache, seizures, slurred speech, difficulty in depth perception.
Psychiatric:
Agitation, mental confusion, depression, irritability, nervousness, sleep disturbances, euphoria, lethargy, stupor.
Gastrointestinal:
Dry mouth, nausea, nonspecific gastrointestinal disturbances, vomiting.
Musculoskeletal:
Muscle spasm, muscle weakness.
Cardiovascular:
Hypotension, palpitations, tachycardia.
Dermatologic:
Pruritus, rash.
Genitourinary:
Incontinence, change in libido.
Hematologic:
Decreased hemoglobin and hematocrit, increased and decreased WBC.
Hepatic:
Elevations of alkaline phosphatase, bilirubin, AST (SGOT), ALT (SGPT).
Miscellaneous:
Increased and decreased blood sugar levels.
Overdose Back to top of page
Symptoms:Manifested as an extension of alprazolam's pharmacologic activity. Varying degrees of CNS depressant effects such as somnolence and hypnosis can occur. Other manifestations may include muscle weakness, ataxia, dysarthria and particularly in children paradoxical excitement. In more severe cases diminished reflexes, confusion and coma may ensue. It should be remembered when treating an overdose that multiple agents may have been ingested. Fatalities with benzodiazepines rarely occur except when other drugs, alcohol or aggravating factors are involved.
Treatment:
Vomiting may be induced if the patient is fully awake. Vital signs should be monitored and general supportive measures should be employed as indicated. Gastric lavage should be instituted as soon as possible. I.V. fluids may be administered and an adequate airway should be maintained.
Experiments in animals have indicated that cardiopulmonary collapse can occur with massive i.v. doses of alprazolam. This could be reversed with positive mechanical respiration and the i.v. infusion of levarterenol.
Animal experiments with alprazolam and related compounds have suggested that hemodialysis and forced diuresis are probably of little value.
Dosage
Must be individualized and carefully titrated in order to avoid excessive sedation or mental and motor impairment. As with other anxiolytic-sedatives, short courses of treatment should be the rule for the symptomatic relief of excessive anxiety and the initial course of treatment should not last longer than 1 week without reassessment. If necessary, drug dosage can be adjusted after 1 week. Prescriptions should be limited to short courses of therapy.Adults:
Initially: Back to top of page
0.25 mg (250 mcg) given 2 or 3 times daily. If required, increases may be made in 0.25 mg (250 mcg) increments according to the severity of symptoms and patient response. It is recommended that the evening dose be increased before the daytime doses. Very severe manifestations of anxiety may require larger initial daily doses. The optimal
dosage is one that permits symptomatic control of excessive anxiety without impairment of mental and motor function. Exceptionally, it may be necessary to increase dosage to a maximum of 3 mg daily, given in divided doses.
Elderly and Debilitated Patients:
The initial dosage is 0.125 mg (125 mcg) 2 or 3 times daily. If necessary, this dosage may be increased gradually depending on patient tolerance and response.
Supplied Back to top of page
Xanax:0.25 mg:
Each scored white, ovoid-shaped tablet, coded "Upjohn 29," contains: Alprazolam 0.25 mg (250 mcg). Gluten-free. Bottles of 100 and 1000.
0.5 mg:
Each scored, peach, ovoid-shaped tablet, coded "Upjohn 55," contains: Alprazolam 0.5 mg (500 mcg). Gluten-free. Bottles of 100 and 1000.
1 mg:
Each scored, lavender, ovoid-shaped tablet, coded "Upjohn 90" contains: Alprazolam 1 mg (1000 mcg). Gluten-free. Bottles of 100.
Xanax TS:
2 mg:
Each white, triscored tablet (3 scores), with the number "2" on one side and Xanax on the other side contains: Alprazolam 2 mg. The tablets can be broken into 4 equal parts of 0.5 mg. Bottles of 100.